Nanoparticle-mediated Zn delivery impacts neural protein phosphatase activity

Area of Science:

• Neuroscience
• Materials Science
• Biochemistry

Background:

• Nanoparticles (NPs) are increasingly researched for medical diagnosis and treatment.
• Zinc oxide nanoparticles (ZnO NP) show varied effects on brain health, with some studies suggesting neuroprotection and others indicating neurotoxicity.
• Previous research indicated beneficial effects of zinc (Zn) cations in Alzheimer's disease (AD) models.

Purpose of the Study:

• To investigate the impact of ZnO NP on protein aggregation.
• To explore the influence of ZnO NP on protein phosphorylation in Alzheimer's disease (AD) pathology.
• To evaluate ZnO NP as a potential delivery system for zinc (Zn) in neurological applications.

Main Methods:

• Cultured neuronal cells were used to assess the effects of ZnO NP.
• Protein aggregation levels were measured in response to ZnO NP treatment.
• Protein phosphorylation events, including those related to tau and amyloid precursor protein (APP), were analyzed.

Main Results:

• ZnO NP treatment led to a reduction in protein aggregation within neuronal cells.
• However, ZnO NP decreased the activity of protein phosphatases PP1 and PP2A.
• This phosphatase inhibition potentially increased the phosphorylation of tau and APP, hallmarks of AD.

Conclusions:

• While ZnO NP may reduce protein aggregation, they can induce detrimental molecular changes relevant to AD.
• The use of NPs as a zinc (Zn) delivery system presents a dual-edged effect on cellular processes.
• A comprehensive approach is necessary to understand the multifaceted impacts of NPs in biological systems.